Xconomy Boston

Thermo Fisher MRSA Test Approved

Rebecca Zacks4/4/08

The FDA has approved a new test for the “superbug” methicillin-resistant Staphylococcus aureus (MRSA), according to the manufacturer, Waltham, MA-based Thermo Fisher Scientific (NYSE: TMO). The test, called Spectra MRSA, gives results within a day and integrates with routine lab systems to aid healthcare facilities’ efforts to screen their patients, the company said.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.